In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)


Class-Action Tracker

Zantac Heartburn Medication

Class Action

Zantac Heartburn Medication

In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…


The Latest

Filters

Spectrum Mobile

Ad Alert

Spectrum Mobile

Inquiry finds price comparison uses wireless carrier’s lowest tier plan but not one of its competitors.

Brillia

Ad Alert

Brillia

What consumers should know about this purported homeopathic product.


Show More